Bayesian Capital Management’s Exelon EXC Stock Holding History

Bayesian Capital Management’s Portfolio EXC Stock Details EXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-9,625	Closed	-$433K	–	264
2025 Q3	$433K	Buy	+9,625	New	+$423K	0.09%	308
2025 Q1	–	Sell	-164,100	Closed	-$6.18M	–	721
2024 Q4	$6.18M	Buy	+164,100	New	+$6.37M	0.76%	11
2023 Q3	–	Sell	-47,200	Closed	-$1.92M	–	787
2023 Q2	$1.92M	Buy	+47,200	New	+$1.95M	0.21%	133
2021 Q3	–	Sell	-16,263	Closed	-$514K	–	432
2021 Q2	$514K	Buy	+16,263	New	+$524K	0.13%	186
2021 Q1	–	Sell	-26,918	Closed	-$811K	–	582
2020 Q4	$811K	Buy	+26,918	New	+$794K	0.21%	134
2019 Q3	–	Sell	-57,622	Closed	-$1.97M	–	571
2019 Q2	$1.97M	Buy	+57,622	New	+$2.03M	0.41%	67
2018 Q4	–	Sell	-14,861	Closed	-$463K	–	658
2018 Q3	$463K	Buy	+14,861	New	+$457K	0.08%	352

Other funds holding EXC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bayesian Capital Management's EXC Position: Q4 2025 in Review

Bayesian Capital Management sold out of Exelon (EXC) in Q4 2025, closing a stake of 9,625 shares — an estimated $433K sold.

Bayesian Capital Management first reported a position in EXC in Q3 2018 and held it in 7 quarters. The position peaked at $6.18M in Q4 2024. 1,248 funds tracked by Wall St. Rank hold EXC as of Q4 2025.

Bayesian Capital Management reported no remaining Exelon position as of Q4 2025 after selling out during the quarter.
Bayesian Capital Management sold 9,625 Exelon shares in Q4 2025, an estimated $433K.
Bayesian Capital Management first reported a position in Exelon in Q3 2018 and held it in 7 quarters.
Bayesian Capital Management's Exelon position peaked at $6.18M in Q4 2024.
1,248 funds tracked by Wall St. Rank held Exelon as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.